Skip to content
HowShorted

Emergent Biosolutions, Inc. short interest in 2024

In 2024, Emergent Biosolutions, Inc.'s disclosed short interest ran from 22.77% of shares outstanding on 12 Jan 2024 to 13.17% on 31 Dec 2024, a change of -9.60 percentage points. The year's high was 22.77% on 12 Jan 2024 and its low 6.54% on 15 Aug 2024, averaging 12.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.44 days on 31 Jan 2024. Full history: Emergent Biosolutions, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Emergent Biosolutions, Inc. in 2024

2024 in figures

Start of year
22.77% (12 Jan 2024)
End of year
13.17% (31 Dec 2024)
Change
-9.60 pp
High
22.77% (12 Jan 2024)
Low
6.54% (15 Aug 2024)
Average
12.49%
Highest days to cover
10.44 (31 Jan 2024)
SEC filings marked
9

Every report in 2024

Emergent Biosolutions, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202422.77%8.25
31 Jan 202420.11%10.44
15 Feb 202422.23%7.56
29 Feb 202411.95%1.00
15 Mar 20249.47%1.75results (8-K), 10-K filed
28 Mar 202410.99%5.01
15 Apr 202411.36%5.53
30 Apr 202413.61%7.36
15 May 202411.52%1.00results (8-K), 10-Q filed
31 May 202411.33%2.93
14 Jun 202412.08%2.88
28 Jun 20249.91%1.78
15 Jul 20248.70%1.63
31 Jul 20246.98%1.36
15 Aug 20246.54%1.00results (8-K), 10-Q filed
30 Aug 20247.25%1.00
13 Sep 20248.45%2.73
30 Sep 202415.55%2.95
15 Oct 202414.73%5.49results (8-K)
31 Oct 202412.82%5.83
15 Nov 202412.57%3.42results (8-K), 10-Q filed
29 Nov 202412.78%5.96
13 Dec 202412.80%7.73
31 Dec 202413.17%5.74

See also: Emergent Biosolutions, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.